Clare Market Investments’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,849
Closed -$310K 134
2023
Q2
$310K Sell
4,849
-592
-11% -$39.7K 0.12% 97
2023
Q1
$377K Sell
5,441
-3,243
-37% -$229K 0.16% 77
2022
Q4
$625K Sell
8,684
-9,885
-53% -$745K 0.29% 49
2022
Q3
$1.32M Sell
18,569
-2,899
-14% -$210K 0.57% 23
2022
Q2
$1.65M Buy
21,468
+9,234
+75% +$703K 0.72% 18
2022
Q1
$893K Buy
12,234
+8,668
+243% +$582K 0.28% 51
2021
Q4
$222K Sell
3,566
-1,354
-28% -$79.4K 0.06% 138
2021
Q3
$291K Sell
4,920
-295
-6% -$19.4K 0.09% 110
2021
Q2
$349K Sell
5,215
-1,751
-25% -$114K 0.11% 96
2021
Q1
$440K Sell
6,966
-60
-0.9% -$3.73K 0.17% 70
2020
Q4
$436K Sell
7,026
-4,004
-36% -$246K 0.18% 68
2020
Q3
$665K Sell
11,030
-813
-7% -$48.9K 0.33% 49
2020
Q2
$696K Buy
11,843
+534
+5% +$31.9K 0.41% 40
2020
Q1
$631K Buy
11,309
+1,735
+18% +$106K 0.53% 30
2019
Q4
$615K Buy
9,574
+4,579
+92% +$262K 0.44% 47
2019
Q3
$253K Sell
4,995
-929
-16% -$43.7K 0.24% 64
2019
Q2
$269K Sell
5,924
-760
-11% -$35.4K 0.21% 78
2019
Q1
$319K Buy
6,684
+1,744
+35% +$86.9K 0.28% 75
2018
Q4
$257K Buy
+4,940
New +$265K 0.33% 58

Other funds holding BMY

Clare Market Investments's BMY Position: Q3 2023 in Review

Clare Market Investments sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 4,849 shares — an estimated $310K sold.

Clare Market Investments first reported a position in BMY in Q4 2018 and held it in 19 quarters. The position peaked at $1.65M in Q2 2022. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • Clare Market Investments reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • Clare Market Investments sold 4,849 Bristol-Myers Squibb shares in Q3 2023, an estimated $310K.
  • Clare Market Investments first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 19 quarters.
  • Clare Market Investments's Bristol-Myers Squibb position peaked at $1.65M in Q2 2022.
  • 2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Clare Market Investments's 13F filing for Q3 2023, filed 20 Feb 2025.